Although extensive research over the years has shed light on the metastasis suppressing potential of KAI1 in prostate cancer, limited studies exist in regard to breast cancer and particularly in relation to KAI1 expression with clinicopathological features. The gene discussed is CD82; the disease is prostate cancer.